New optically pure compounds for improved therapeutic efficiency

Details for Australian Patent Application No. 2008356840 (hide)

Owner Centre National De La Recherche Scientifique (CNRS) Immupharma (France)

Inventors Zimmer, Robert; Briand, Jean Paul; Courty, Jose; Guichard, Gilles; Zhang, Haixiang; Lang, Annie; Devin, Chantal

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2008356840

PCT Pub. Number WO2009/141687

Filing date 22 May 2008

Wipo publication date 26 November 2009

International Classifications

C07K 5/02 (2006.01) Peptides having up to four amino acids in a fully defined sequence

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

16 December 2010 PCT application entered the National Phase

  PCT publication WO2009/141687 Priority application(s): WO2009/141687

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008356844-Dental implant fixture

2008356829-Device for providing information on positioning of a moveable coupling of a marine fluid loading system